BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma
Authors:
Open Access
- 28 August 2014
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 8 (5) , 1947-1952
Abstract
Long non‑coding RNAs (lncRNAs) are novel regulators in cancer biology. BRAF‑activated lncRNA (BANCR) is overexpressed in melanoma and has a potential functional role in melanoma cell migration. However, little is known about the role of BANCR in the development of papillary thyroid carcinoma (PTC). In the present study, BANCR expression was examined in six pairs of PTC and matched adjacent normal tissues. The results revealed that BANCR levels were significantly higher in the PTC tissues and PTC IHH‑4 cells compared with the normal controls. Knockdown of BANCR in the IHH‑4 cells inhibited proliferation and increased apoptosis of the cells in vitro. Further investigation of the underlying mechanisms revealed that BANCR markedly activated autophagy. Overexpression of BANCR inhibited apoptosis in the IHH‑4 cells, whereas inhibition of autophagy stimulated apoptosis in the BANCR‑overexpressed cells. BANCR overexpression also increased cell proliferation and the inhibition of autophagy abrogated BANCR overexpression‑induced cell proliferation. In addition, the overexpression of BANCR resulted in an increase in the ratio of LC3‑II/LC3‑I, a marker for autophagy, while the knockdown of BANCR decreased the ratio of LC3‑II/LC3‑I. These results revealed that BANCR expression levels are upregulated in PTC. Additionally, BANCR increases PTC cell proliferation, which could activate autophagy.Keywords
This publication has 18 references indexed in Scilit:
- Long noncoding RNAs: New regulators in plant developmentBiochemical and Biophysical Research Communications, 2013
- Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expressionBiochemical and Biophysical Research Communications, 2013
- A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cellsExperimental and Therapeutic Medicine, 2013
- Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde?Cancer Letters, 2012
- BRAF V600E Mutation Independently Predicts Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid CancerAnnals of Surgical Oncology, 2012
- Tumor cells can evade dependence on autophagy through adaptationBiochemical and Biophysical Research Communications, 2012
- Cell death pathology: Cross-talk with autophagy and its clinical implicationsBiochemical and Biophysical Research Communications, 2011
- BRAF V600E Maintains Proliferation, Transformation, and Tumorigenicity of BRAF-Mutant Papillary Thyroid Cancer CellsThe Journal of Clinical Endocrinology & Metabolism, 2007
- Thyroid carcinomaThe Lancet, 2003
- Mutations of the BRAF gene in human cancerNature, 2002